Biomarkers for the Early Diagnosis of Sepsis in Burns: Systematic Review and Meta-analysis. Issue 4 (27th April 2022)

• Record Type: Journal Article
• Authors: Li, Andrew T.; Moussa, Anthony; Gus, Eduardo; Paul, Eldho; Yii, Erwin; Romero, Lorena; Lin, Zhiliang Caleb; Padiglione, Alexander; Lo, Cheng Hean; Cleland, Heather; Cheng, Allen C.
• Is Part Of: Annals of surgery. Volume 275:Issue 4(2022)
• Page Start: 654
• Page End: 662
• Publication Date: 2022-04-27
• Subjects: burns -- diagnosis -- meta-analysis -- sepsis -- systematic review; Surgery -- Periodicals; 617.005
• DOI: 10.1097/SLA.0000000000005198
• Languages: English
• ISSNs: 0003-4932

Abstract

Abstract : Objective: The aim of this study was to evaluate the diagnostic performance of all biomarkers studied to date for the early diagnosis of sepsis in hospitalized patients with burns. Background: Early clinical diagnosis of sepsis in burns patients is notoriously difficult due to the hypermetabolic nature of thermal injury. A considerable variety of biomarkers have been proposed as potentially useful adjuncts to assist with making a timely and accurate diagnosis. Methods: We searched Medline, Embase, Cochrane CENTRAL, Biosis Previews, Web of Science, and Medline In-Process to February 2020. We included diagnostic studies involving burns patients that assessed biomarkers against a reference sepsis definition of positive blood cultures or a combination of microbiologically proven infection with systemic inflammation and/or organ dysfunction. Pooled measures of diagnostic accuracy were derived for each biomarker using bivariate random-effects meta-analysis. Results: We included 28 studies evaluating 57 different biomarkers and incorporating 1517 participants. Procalcitonin was moderately sensitive (73%) and specific (75%) for sepsis in patients with burns. C-reactive protein was highly sensitive (86%) but poorly specific (54%). White blood cell count had poor sensitivity (47%) and moderate specificity (65%). All other biomarkers had insufficient studies to include in a meta-analysis, however brain natriuretic peptide, stroke volume index, tumor necrosis factor (TNF)-alpha, and cell-free DNA (on day 14 post-injury) showed the most promise in single studies. There was moderate to significant heterogeneity reflecting different study populations, sepsis definitions and test thresholds. Conclusions: The most widely studied biomarkers are poorly predictive for sepsis in burns patients. Brain natriuretic peptide, stroke volume index, TNF-alpha, and cell-free DNA showed promise in single studies and should be further evaluated. A standardized approach to the evaluation of diagnostic markers (including time of sampling, cut-offs, and outcomes) would be useful.